Similar effect of tocilizumab, an interleukin-6 receptor antagonist, administered either intravenously or subcutaneously on lipid levels in rheumatoid arthritis

Autor:	Eirini Devetzi, Aikaterini Tzanavari, Panagiotis Athanassiou, Lambros Athanassiou, Maria Mavroudi, Ifigenia Kostoglou-Athanassiou, Pavlos Tsakiridis, Marina Gatsiou
Rok vydání:	2020
Předmět:	chemistry.chemical_compound Tocilizumab chemistry business.industry Rheumatoid arthritis medicine Interleukin-6 Receptor Antagonist Pharmacology medicine.disease business
Zdroj:	Endocrine Abstracts.
ISSN:	1479-6848
DOI:	10.1530/endoabs.70.ep130
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::de84eb14d1d48c57333e61762685c9b7 https://doi.org/10.1530/endoabs.70.ep130 Zobrazit plný text záznamu